On the other hand, the oxidative stress would also be altered by the presence of GLP-1 agonist in which glomerular sclerosis and oxidative stress were decreased after the addition of GLP-1 agonist in experimental research [31]. This evidence concerns the gene GCG and glomerulosclerosis.